Cargando…
Advances in Development of New Treatment for Leishmaniasis
Leishmaniasis is a neglected infectious disease caused by several different species of protozoan parasites of the genus Leishmania. Current strategies to control this disease are mainly based on chemotherapy. Despite being available for the last 70 years, leishmanial chemotherapy has lack of efficie...
Autores principales: | de Menezes, Juliana Perrone Bezerra, Guedes, Carlos Eduardo Sampaio, Petersen, Antônio Luis de Oliveira Almeida, Fraga, Deborah Bittencourt Mothé, Veras, Patrícia Sampaio Tavares |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442256/ https://www.ncbi.nlm.nih.gov/pubmed/26078965 http://dx.doi.org/10.1155/2015/815023 |
Ejemplares similares
-
Elucidating the role played by bone marrow in visceral leishmaniasis
por: Veras, Patricia Sampaio Tavares, et al.
Publicado: (2023) -
In Search of Biomarkers for Pathogenesis and Control of Leishmaniasis by Global Analyses of Leishmania-Infected Macrophages
por: Veras, Patricia Sampaio Tavares, et al.
Publicado: (2018) -
Using Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish Infection
por: Veras, Patrícia Sampaio Tavares, et al.
Publicado: (2016) -
In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
por: Guedes, Carlos Eduardo Sampaio, et al.
Publicado: (2018) -
Multi-antigen print immunoassay (MAPIA)-based evaluation of novel recombinant Leishmania infantum antigens for the serodiagnosis of canine visceral leishmaniasis
por: de Oliveira, Isaac Queiroz, et al.
Publicado: (2015)